Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas

Anticancer Research

Volumn 25, Issue 3 B, 2005, Pages 2065-2068

  Pisano, Carmela ^a   Ottaiano, Alessandro ^a   Tatangelo, Fabiana ^a   Di Bonito, Maurizio ^a   Falanga, Marzia ^a   Iaffaioli, Vincenzo Rosario ^a   Botti, Gerardo ^a   Pignata, Sandro ^a   Acquaviva, Angela Maria ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Colorectal adenomas; Colorectal cancer; Cyclooxygenase 2

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; CARCINOGENESIS; COLORECTAL ADENOMA; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PARAFFIN EMBEDDING; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 21344465174     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ: Cancer statistics, 2003. CA - Cancer J Clin 53: 5-26, 2003.
2. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
3. Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Presinger AC, Hedge P, Silverman GA and Vogelstein B: The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 19: 525-531, 1994.
4. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JK, Markowitz S, Hamilton SR, Kern SE, Kinzler KW and Vogelstein B: Evaluation of candidate tumor suppressor genes on chromosome 18 in colorectal careers. Nat Genet 13: 343-346, 1996.
5. Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B: A model for p53-induced apoptosis. Nature 389: 300-305, 1997.
6. Irby RB, Mao W, Coppola D, Kang J, Loubeau JM, Trudeau W, Karl R, Fujita DJ, Jove R and Yeatman TJ: Activating SRC mutation in a subset of advanced human colon cancers. Nat Genet 21: 187-190, 1999.
7. Dicato M, Berchem G, Duhem C and Ries F: The biology of colorectal cancer. Semin Oncol 27: 2-9, 2000.
8. Thum MJ, Namboodiri MM and Heath CW Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596, 1991.
9. Ricchi P, Zarrilli R, Di Palma A and Acquaviva AM: Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy. Br J Cancer 88: 803-807, 2003.
10. Giardiello FM, Hamilton SR, Krush AJ, Piantoadosi S, Hylind LM, Celano P, Booker SV, Robison CR and Offerhaus GJ: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328: 1313-1316, 1993.
11. Boojbool SK, Dannenberg AJ, Chadburn A, Martucci C, Guo XJ, Ramonetti JT, Abreu-Goris M, Newmark HL, Lipkin ML, DeCosse JJ and Bertagonolli MM: Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res 56: 2556-2560, 1996.
12. DuBois RN, Radhika A, Reddy BS and Entingh AJ: Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 110: 1259-1262, 1996.
13. Smith ML, Hawcroft G and Hull MA: The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer 36: 664-674, 2000.
14. Falkowski M, Skogstad S, Shahzidi S, Smedsrod B and Sveinbjornsson B: The effect of cyclooxygenase inhibitor diclofenac on experimental murine colon carcinoma. Anticancer Res 23(3B): 2303-2308, 2003.
15. Yamaguchi A, Ishida T, Nishimura G, Katoh M and Miyazaki I: Investigation of colonic prostaglandins in carcinogenesis in the rat colon. Dis Colon Rectum 34: 572-576, 1991.
16. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA and Jothy S: Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55: 2556-2559, 1995.
17. Dimberg J, Samuelsson A, Hugander A and Soderkvist P: Differential expression of cyclooxygenase 2 in human colorectal cancer. Gut 45: 730-732, 1999.
18. Williams CS, Mann M and DuBios RN: The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18: 7908-7916, 1999.
19. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ and Seibert K: Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60: 1306-1311, 2000.
20. Cao Y and Prescott SM: Many actions of cycooxygenase-2 in cellular dynamics and in cancer. J Cell Physiol 190: 279-286, 2002.
21. Dobbie Z, Muller PY, Heinimann K, Albrecht C, D'Orazio D, Bendik L, Muller H and Bauerfeind P: Expression of COX-2 and Wnt pathway genes in adenomas on familiar adenomatous polyposis patients treated with meloxicam. Anticancer Res 22(4): 2215-2220, 2002.
22. Yamauchi T, Watanabe M, Hasegawa H, Nishibori H, Ishii Y, Tatematsu H, Yamamoto K, Kubota T and Kitajima M: The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Anticancer Res 23(1A): 245-249, 2003.
23. Kakiuchi Y, Tsuji S, Tsujii M, Murata H, Kawai N, Yasumaru M, Kimura A, Komori M, Irie T, Miyoshi E, Sasaki Y, Hayashi N, Kawano S and Hori M: Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 62: 1567-1572, 2002.
24. Rubio CA: Further studies on the histological characteristics linked to local tumour invasion in colorectal carcinomas. Anticancer Res 23(4): 3555-3560, 2003.
25. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF and Taketo MM: Suppression of intestinal polyposis in Apc_716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803-809, 1996.
26. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87: 159-170, 1996.
27. Petersen S, Haroske G, Hellmich G, Ludwig K, Petersen C and Eicheler W: COX-2 expression in rectal carcinoma: immunohistochemical pattern and clinical outcome. Anticancer Res 22(2B): 1225-1230, 2002.
28. Hao X, Bishop AE, Wallace M, Wang H, Willcocks TC, Maclouf J, Polak JM, Knight S and Talbot IC: Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 187: 295-301, 1999.
29. Einspahr JG, Krouse RS, Yochim JM, Danenberg PV, Danenberg KD, Bhattacharyya AK, Martinez ME and Alberts DS: Association between cyclooxygenase expression and colorectal adenoma characteristics. Cancer Res 63: 3891-3893, 2003.
30. Chapple KS, Cartwright EJ, Hawcroft G, Tisbury A, Bonifer C, Scott N, Windsor AC, Guillou PJ, Markham AF, Coletta PL and Hull MA: Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 156: 545-553, 2000.
31. Elder DJ, Baker JA, Banu NA, Moorghen M and Paraskeva C: Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression. J Pathol 198: 428-434, 2002.
32. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S and DuBois RN: Up-regulation of cyclooxygenase-2 gene expression in human colo-rectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188, 1994.
33. Hasegawa K, Ichikawa W, Fujita T, Ohno R, Okusa T, Yoshinaga K and Sugihara K: Expression of cyclooxygenase-2 (COX-2) mRNA in human colorectal adenomas. Eur J Cancer 37: 1469-1474, 2001.
34. Sheehan KM, Sheehan K, O'Donoghue DP, MacSweeney F, Conroy RN, Fitzgerald DJ and Murray FE: The relationship between cyclooxygenase-2 expression and colorectal cancer. J Am Med Assoc 282: 1254-1257, 1999.